Jan 18, 2019 -
Jan 18, 2019 - Aerie's (AERI) Investigational New Drug Application for AR-1105 for the treatment of macular edema due to retinal vein occlusion is accepted by the FDA. The candidate will now enter clinical studies.
Jan 09, 2019 - It was a busy week for the biotech sector with most companies gaining on M&A activity. The annual J.P. Morgan Healthcare conference were also a key area of focus.
Jan 08, 2019 - Regeneron Pharmaceuticals Inc (NASDAQ:REGN) 37th Annual J.P. Morgan Healthcare Conference January 7, 2019 1:30 PM ET Company Participants Leonard Schleifer - Founder, President and Chief Executive Off
Jan 08, 2019 - We discuss a few attractive biotech companies that flaunt solid product portfolios, deep pipelines and lucrative valuations to emerge as likely acquisition targets in 2019.
Jan 07, 2019 - Regeneron (REGN) amends its existing agreement with Sanofi and selects two clinical-stage bispecific antibodies for the ongoing collaboration.
Jan 04, 2019 - Names on the move ahead of the open.
Dec 27, 2018 - The biotech sector not only has helped to discover cures to difficult medical problems but also has outperformed the broader market. Tekla Healthcare Investors (HQH) is a CEF which provides investors
Dec 18, 2018 - REGN is retracing its levels from January 2018 after hitting lows in May and highs in September.Revenue continues to grow and REGN has a strong history of growth.Still, there are concerns and sell-off
Dec 17, 2018 - Although PEG ratio is categorized under value investing, this strategy follows the principles of both growth and value investing.